Ingevity (NYSE:NGVT – Get Free Report) is one of 296 public companies in the “Chemicals” industry, but how does it compare to its peers? We will compare Ingevity to similar businesses based on the strength of its profitability, institutional ownership, analyst recommendations, dividends, risk, earnings and valuation.
Profitability
This table compares Ingevity and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Ingevity | 5.28% | 405.38% | 11.41% |
| Ingevity Competitors | -54.13% | -0.44% | -1.36% |
Analyst Ratings
This is a summary of current ratings and price targets for Ingevity and its peers, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Ingevity | 0 | 3 | 2 | 0 | 2.40 |
| Ingevity Competitors | 3275 | 12246 | 14161 | 521 | 2.39 |
Ingevity currently has a consensus price target of $80.00, indicating a potential upside of 32.40%. As a group, “Chemicals” companies have a potential upside of 8.91%. Given Ingevity’s stronger consensus rating and higher probable upside, analysts plainly believe Ingevity is more favorable than its peers.
Earnings and Valuation
This table compares Ingevity and its peers revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Ingevity | $1.17 billion | -$167.10 million | 35.54 |
| Ingevity Competitors | $7.97 billion | $229.42 million | 7.29 |
Ingevity’s peers have higher revenue and earnings than Ingevity. Ingevity is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Volatility & Risk
Ingevity has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500. Comparatively, Ingevity’s peers have a beta of 0.94, indicating that their average share price is 6% less volatile than the S&P 500.
Insider & Institutional Ownership
91.6% of Ingevity shares are owned by institutional investors. Comparatively, 48.0% of shares of all “Chemicals” companies are owned by institutional investors. 0.9% of Ingevity shares are owned by company insiders. Comparatively, 13.9% of shares of all “Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Summary
Ingevity beats its peers on 8 of the 13 factors compared.
About Ingevity
Ingevity is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. It develops and manufactures high-performance activated carbon and specialty chemical products for industrial and consumer applications. Its activated carbon products are used in vehicle fuel-vapor emission control and other applications. The company also makes specialty chemicals and polymer materials used in areas such as pavement technologies, coatings, adhesives and elastomers. Ingevity serves customers in markets around the world.
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
